Principal Investigator
Overview
Start/End Dates
Locations
Vancouver General Hospital
Name/Title
Claudia Piechnik, Research Operations Manager
Phone
Email Address
Purpose of Study
The purpose of this study is to evaluate the safety, efficacy and tolerability of subcutaneous (SC) blinatumomab for treatment of acute lymphoblastic leukemia and to determine the maximum tolerated dose and preliminary recommended phase 2 dose(s) of SC administered blinatumomab.
Eligibility
Visit ClinicalTrials.gov for more information.
Disclaimer
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.
Start/End Dates
Locations
Vancouver General Hospital
Name/Title
Claudia Piechnik, Research Operations Manager
Phone
Email Address
Purpose of Study
The purpose of this study is to evaluate the safety, efficacy and tolerability of subcutaneous (SC) blinatumomab for treatment of acute lymphoblastic leukemia and to determine the maximum tolerated dose and preliminary recommended phase 2 dose(s) of SC administered blinatumomab.
Eligibility
Visit ClinicalTrials.gov for more information.
Disclaimer
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.
